Skip to main content
Publication, Part of

Statistics on NHS Stop Smoking Services in England April 2017 to September 2017

Official statistics
Publication Date:
Geographic Coverage:
Geographical Granularity:
Regions, Local Authorities
Date Range:
01 Apr 2017 to 30 Sep 2017


This quarterly report presents results from the monitoring of the NHS Stop Smoking Services in England during the period April 2017 to September 2017. NHS Stop Smoking Services offer support to help people quit smoking. This can include intensive support through group therapy or one-to-one support. The support is designed to be widely accessible within the local community and is provided by trained personnel, such as specialist smoking cessation advisors and trained nurses and pharmacists.

This report includes information on the number of people setting a quit date and the number who successfully quit at the 4 week follow-up. It also presents in depth analyses of the key measures of the service including pregnant women, breakdowns by ethnic group and type of pharmacotherapy received. The results are provided at national, regional and local authority levels.

Key Facts

•134,101 people set a quit date and at the 4 week follow-up 65,876 people (49 per cent) had successfully quit (self-reported) .
•72 per cent of these successful quitters had their results confirmed by Carbon Monoxide verification .
•Quitting success increased with age, from 41 per cent of those aged under 18, to 55 per cent of those aged 60 and over.
•Yorkshire and the Humber had the highest proportion of successful quitters (58 per cent), whilst the South West had the lowest proportion (42 per cent).
•Slough had the highest proportion of successful quitters (85 per cent) followed by Staffordshire (82 per cent). Cumbria had the lowest proportion (23 per cent).
•44 per cent of the pregnant women who set a quit date successfully quit.
•38 per cent of people accessed Stop Smoking Services through their GP.
•81 per cent of people used one-to-one support to help themselves quit smoking.
•The most common pharmacotherapy was a combination of licensed Nicotine Containing Products taken concurrently (33 per cent).


Related Links

Last edited: 11 April 2018 5:22 pm